Anakinra for Myocarditis in Juvenile Idiopathic Arthritis

被引：0
|
作者：
Movva, Rajesh [1 ]
Brown, Suzanne B. [1 ]
Morris, D. Lynn [1 ,2 ]
Figueredo, Vincent M. [1 ,2 ]
机构：
[1] Albert Einstein Med Ctr, Div Cardiol, Philadelphia, PA 19141 USA
[2] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA
来源：
TEXAS HEART INSTITUTE JOURNAL | 2013年 / 40卷 / 05期
关键词：
Anti-inflammatory agents/therapeutic use; antirheumatic agents/therapeutic use; arthritis; juvenile rheumatoid/complications/drug therapy; disease susceptibility; heart/drug effects; interferon-beta/therapeutic use; interleukin 1 receptor antagonist protein; myocarditis/diagnosis; treatment outcome; ventricular dysfunction; left/drug effects; LEFT-VENTRICULAR FUNCTION; RECEPTOR ANTAGONIST; HEART-FAILURE; INTERLEUKIN-1; THERAPY; GLOBULIN; BLOCKADE; ALPHA;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 20-year-old pregnant woman with a history of juvenile idiopathic arthritis presented with flu-like symptoms, systemic inflammation with myocarditis, and severe cardiomyopathy. Six weeks earlier, her chronic-arthritis therapy had been changed from anakinra, an interleukin-1 beta receptor antagonist, to etanercept When she resumed taking anakinra, her condition improved dramatically, including a complete recovery of ventricular function. Myocarditis is a well-recognized complication of systemic vasculitides. This unusual case emphasizes the important pathophysiologic role of interleukin receptors in the successful treatment of myocarditis. We suggest that clinical cardiologists be aware of the therapeutic usefulness of biological agents such as anakinra in patients with rheumatic conditions.
引用
收藏
页码：623 / 625
页数：3
相关论文
共 50 条
  • [41] New treatments for idiopathic juvenile arthritis
    Bader-Meunier, B.
    Quartier, P.
    ARCHIVES DE PEDIATRIE, 2009, 16 (12): : 1607 - 1611
  • [42] Update on the Treatment of Juvenile Idiopathic Arthritis
    Harris, Julia G.
    Kessler, Elizabeth A.
    Verbsky, James W.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2013, 13 (04) : 337 - 346
  • [43] Differences between leukemic arthritis and juvenile idiopathic arthritis
    Jimenez, Alfonso Ragnar Torres
    Vallejo, Eunice Solis
    Cruz, Adriana Ivonne Cespedes
    Miramontes, Julia Veronica Ramirez
    Olvera, Guadalupe del Consuelo Cortina
    Cruz, Alejandra Velazquez
    Jara, Berenice Sanchez
    PEDIATRIC RHEUMATOLOGY, 2023, 21 (01)
  • [44] Treatment strategies for juvenile idiopathic arthritis
    Klein, Ariane
    Horneff, Gerd
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (18) : 3049 - 3060
  • [45] The Diagnosis and Management of Juvenile Idiopathic Arthritis
    Stanley, Leah C.
    Ward-Smith, Peggy
    JOURNAL OF PEDIATRIC HEALTH CARE, 2011, 25 (03) : 191 - 194
  • [46] Methotrexate in the therapy of juvenile idiopathic arthritis
    Holzinger, D.
    Frosch, M.
    Foell, D.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2010, 69 (06): : 496 - +
  • [47] Update on the Treatment of Juvenile Idiopathic Arthritis
    Julia G. Harris
    Elizabeth A. Kessler
    James W. Verbsky
    Current Allergy and Asthma Reports, 2013, 13 : 337 - 346
  • [48] Systemic onset juvenile idiopathic arthritis
    Frosch, M.
    Holzinger, D.
    Roth, J.
    MONATSSCHRIFT KINDERHEILKUNDE, 2012, 160 (03) : 217 - +
  • [49] Adherence to methotrexate in juvenile idiopathic arthritis
    Pelajo, Christina F.
    Sgarlat, Caitlin M.
    Lopez-Benitez, Jorge M.
    Oliveira, Sheila K. F.
    Rodrigues, Marta C. F.
    Sztajnbok, Flavio R.
    Diniz, Christianne C.
    Miller, Laurie C.
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (02) : 497 - 500
  • [50] Treatment of systemic juvenile idiopathic arthritis
    Hinze, Claas H.
    Foell, Dirk
    Kessel, Christoph
    NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (12) : 778 - 789
12345